00876.HK
Kaisa Health Group Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 1.96
−2.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 520.5M | 139.1M | 185.4M | 185.9M | 191.5M |
| Cost of Revenue | 318.1M | 88.5M | 103.5M | 104.8M | 108.9M |
| Gross Profit | 202.5M | 50.6M | 81.9M | 81.1M | 82.6M |
| Operating Expenses | |||||
| R&D Expense | 48.2M | 16.9M | 12.5M | 16.8M | 17.4M |
| SG&A Expense | 251.6M | 89.1M | 93.6M | 110.2M | 134.8M |
| General & Admin Expense | 61.4M | 35.1M | 46.0M | 57.9M | 86.4M |
| Selling & Marketing Expense | 74.9M | 51.2M | 47.6M | 49.5M | 46.1M |
| Other Expenses | — | — | (983.0K) | — | — |
| Total Operating Expenses | 299.8M | 106.0M | 105.1M | 127.1M | 152.2M |
| Cost and Expenses | 617.8M | 194.5M | 208.6M | 231.9M | 261.2M |
| Operating Income (EBIT) | (97.3M) | (55.4M) | (23.2M) | (40.9M) | (69.7M) |
| Non-Operating | |||||
| Interest Income | 1.0M | 781.0K | 1.3M | 3.1M | 3.0M |
| Interest Expense | 12.1M | 592.0K | 779.0K | 3.7M | 7.7M |
| Net Interest Income | (11.9M) | 189.0K | 536.0K | (594.0K) | (4.7M) |
| Other Non-Op Income/Expense | (42.9M) | 8.4M | (25.5M) | 46.9M | (101.3M) |
| Non-Operating Income (excl Interest) | — | — | 4.6M | (50.6M) | 93.5M |
| EBT (Pre-Tax Income) | (140.2M) | (46.9M) | (48.7M) | 6.0M | (171.0M) |
| Income Tax Expense | (4.3M) | 97.0K | 1.9M | (104.0K) | 1.2M |
| Bottom Line | |||||
| Net Income | (128.9M) | (46.7M) | (46.4M) | 7.5M | (123.3M) |
| Earnings from Cont. Ops | (135.8M) | (46.8M) | (50.6M) | 6.2M | (172.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (128.9M) | (46.7M) | (46.4M) | 7.5M | (123.3M) |
| Per Share | |||||
| Basic EPS | (HK$34.01) | (HK$23.00) | (HK$23.00) | HK$3.75 | (HK$61.25) |
| Diluted EPS | (HK$34.01) | (HK$23.00) | (HK$23.00) | HK$3.75 | (HK$61.25) |
| Revenue Per Share | HK$0.11 | HK$68.97 | HK$91.90 | HK$92.16 | HK$94.95 |
| Shares | |||||
| Basic Shares Outstanding | 4.9B | 2.0M | 2.0M | 2.0M | 2.0M |
| Diluted Shares Outstanding | 4.9B | 2.0M | 2.0M | 2.0M | 2.0M |
| Profitability Metrics | |||||
| EBITDA | (56.0M) | (48.3M) | (12.7M) | 27.6M | (132.0M) |
| D&A | 41.3M | 7.1M | 10.5M | 17.9M | 31.2M |
| EBIT | (97.3M) | (55.4M) | (23.2M) | 9.7M | (163.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026